Stay updated with breaking news from Pfizer Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company data found the Pfizer vaccine was 90.7% effective against symptomatic disease in children ages 5 to 11 and the FDA said the benefits in giving the vaccine to children outweighed the risks.
Company data found the Pfizer vaccine was 90.7% effective against symptomatic disease in children ages 5 to 11 and the FDA said the benefits in giving the vaccine to children outweighed the risks.
28 million children ages 5 to 11 in the United States may be able to receive their Covid-19 vaccine in the first two weeks of November
CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.
Company data found the Pfizer vaccine was 90.7% effective against symptomatic disease in children ages 5 to 11 and the FDA said the benefits in giving the vaccine to children outweighed the risks.